This chapter will discuss the current knowledge of the contribution of systemic and local inflammation in acute and sub-chronic stages of experimental stroke in both the adult and neonate. It will review the role of specific cell types and interactions among blood cells, endothelium, glia, microglia, the extracellular matrix, and neurons -cumulatively called ''neurovascular unit'' -in stroke induction and evolution. Intracellular inflammatory signaling pathways such as nuclear factor kappa beta and mitogen-activated protein kinases, and mediators produced by inflammatory cells such as cytokines, chemokines, reactive oxygen species, and arachidonic acid metabolites, as well as the modifying role of age on these mechanisms, will be reviewed in relation to the potential for therapy in stroke and hypoxic-ischemic injury.
Introduction
For a long time the central nervous system was considered to be ''immunologically privileged'' due to shielding from access by immune cells by the blood-brain barrier (BBB) [1] . However, it is becoming apparent that leukocytes [2], as well as cytokines and chemokines [3] , can cross the intact BBB and that there is a substantial cross-talk between peripheral and local immune components [4, 5] . It is well known that stroke triggers a robust inflammatory reaction characterized by peripheral leukocyte influx into the cerebral parenchyma and activation of endogenous microglia [6] [7] [8] [9] [10] [11] . Following adult stroke, the generation of reactive oxygen species (ROS) and intracellular calcium accumulation in neurons and other brain cells triggers immune responses ultimately leading to inflammatory cell activation and infiltration. Ischemic cells, even ischemic neurons, secrete inflammatory cytokines that cause, among other things, adhesion molecule upregulation in the cerebral vasculature which leads to peripheral leukocyte recruitment. Brain cells are also capable of secreting chemokines, leading to further inflammatory cell chemotaxis into the ischemic lesion. Once activated, inflammatory cells can release a variety of cytotoxic agents including cytokines, matrix metalloproteinases (MMPs), nitric oxide (NO), and more ROS. These substances can contribute to more cell damage as well as disruption of the BBB and extracellular matrix [12] [13] [14] [15] . Fig. 1 demonstrates the conceptual framework for the contribution of inflammatory mechanisms to stroke. Studies in experimental stroke have also shown that the extent, timing and consequences of these processes are profoundly affected by the presence of reperfusion, by gender, genetic background, and by age.
The field of perinatal and neonatal stroke is emerging [16, 17] . Strikingly, the incidence of arterial stroke in newborns, about 1/4000 term babies [18] , is similar to that in the elderly. Although basic mechanisms of neurodegeneration are shared across all age groups, immaturity critically affects brain susceptibility and response to ischemia-related insults (reviewed in [19] [20] [21] [22] ). The inflammatory component of injury is not an exception (see recent reviews [21, 23, 24] ). While signs of inflammation are rapid after both hypoxic encephalopathy and focal stroke in term babies [16, 17] , data for this age group suggest differences in local inflammation, leukocyte-mediated injury, involvement of the BBB and
